Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008

Journal of Hospital Infection

Volumn 77, Issue 1, 2011, Pages 11-15

  McGowan, A P ^a   Lalayiannis, L C ^a   Sarma, J B ^a   Marshall, B ^a   Martin, K E ^a   Welfare, M R ^a  

^a NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Clostridium difficile; Mortality; Outcome data

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL HEALTH SERVICE; PATIENT IDENTIFICATION; PROGNOSIS; RETROSPECTIVE STUDY; UNITED KINGDOM; VITAL SIGN;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; CROSS INFECTION; FECES; FEMALE; GREAT BRITAIN; HOSPITALS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 78650516008     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.09.017     Document Type: Article

References (33)

1. Centre for Infections Healthcare associated infection & antimicrobial resistance department (UK). Surveillance of healthcare associated infections report: 2008 2008, Health Protection Agency, London.
2. Department of Health (UK) A simple guide to Clostridium difficile 2007, Department of Health, London.
3. Healthcare Associated Infection and Antimicrobial Resistance Programme (UK) Healthcare-associated infections in England: 2008-2009 Report 2009, Health Protection Agency, London.
4. Kumar P.J., Clark M.L. Kumar & Clark's clinical medicine 2009, Saunders Elsevier, New York. 7th ed.
5. Commission for Healthcare Audit and Inspection (UK) Investigation into outbreaks of Clostridium difficile at Maidstone and Tunbridge Wells NHS trust 2007, Healthcare Commission, London.
6. Pepin J., Valiquette L., Cossette B. Mortality attributable to nosocomial C. diff.-associated disease during an epidemic caused by a hypervirulent strain in Quebec. Can Med Assoc J 2005, 173:1037-1042.
7. Miller A.T., Tabrizian P., Greenstein A.J., Dikman A., Byrn J., Divino C. Long-term follow-up of patients with fulminant Clostridium difficile colitis. J Gastointest Surg 2009, 13:956-959.
8. Lewis S.J., Heaton K.W. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997, 32:920-924.
9. Kenneally C., Rosini J.M., Skrupky L.P., et al. Analysis of 30-day mortality for Clostridium difficile-associated disease in the ICU setting. Chest 2007, 132:418-424.
10. Henrich T.J., Krakower D., Bitton A., Yokoe D.S. Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis 2009, 15:415-422.
11. Pepin J., Valiquette L., Alary M.E., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991-2003: a changing pattern of disease severity. Can Med Assoc J 2004, 171:466-472.
12. Donnelly R.R. Independent review of Clostridium difficile associated disease at the Vale of Leven Hospital from December 2007 to June 2008 2008, Scottish Government, Edinburgh.
13. Reilly J.S. The effect of surveillance on surgical wound infection rates. J Tissue Viability 1999, 9:57-60.
14. Dudukgian H., Sie E., Gonzalez-Ruiz C., Etzioni D.A., Kaiser A.M. C. difficile colitis - predictors of fatal outcome. J Gastrointest Surg 2010, 14:315-322.
15. Gravel D., Miller M., Simor A., et al. Health-care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program study. Clin Infect Dis 2009, 48:568-576.
16. Bauer MP, Notermans DW, vanBenthem BHB, et al. ESCMID. 20th European Congress of Clinical Microbiology and Infectious Diseases, 10-13 April 2010, Vienna, Austria.
17. Lyytikäinen O., Turunen H., Sund R., et al. Hospitalizations and deaths associated with Clostridium difficile infection, Finland, 1996-2004. Emerg Infect Dis 2009, 15:761-765.
18. Sailhamer E.A., Carson K., Chang Y., et al. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg 2009, 144:433-439.
19. Dubberke E.R., Butler A.M., Reske K.A., et al. Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis 2008, 14:1031-1038.
20. Song X., Bartlett J.G., Speck K., Naegeli A., Carroll K., Perl T.M. Rising economic impact of Clostridium difficile-associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol 2008, 29:823-828.
21. Paltansing S., van den Berg R.J., Guseinova R.A., Visser C.E., van der Vorm, Kuijper E.J. Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands. Clin Microbiol Infect 2007, 13:1058-1064.
22. Ricciardi R., Rothenberger D.A., Madoff R.D., Baxter N.N. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007, 142:624-631.
23. Zerey M., Paton B.L., Lincourt A.E., Gersin K.S., Kercher K.W., Heniford B.T. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect 2007, 8:557-566.
24. Commission for Healthcare Audit and Inspection (UK) Investigation into outbreaks of Clostridium difficile at Stoke Mandeville Hospital, Buckinghamshire Hospitals NHS trust 2006, Healthcare Commission, London.
25. Loo V.G., Poirier L., Miller M.A., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005, 353:2442-2449.
26. Dallal R.M., Harbrecht B.G., Boujoukas A.J., et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002, 235:363-372.
27. Kyne L., Hamel M.B., Polavaram R., Kelly C.P. Health care costs and mortality associated with nosocomial dairrhea due to Clostridium difficile. Clin Infect Dis 2002, 34:346-353.
28. Miller M.A., Hyland M., Ofner-Agostini M., Gourdeau M., Ishak M. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 2002, 23:137-140.
29. Morris A.M., Jobe B.A., Stoney M., Sheppard B.C., Deveney C.W., Deveney K.E. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease?. Arch Surg 2002, 137:1096-1100.
30. Kyne L., Merry C., O'Connell B., Kelly A., Keane C., O'Neill D. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing 1999, 28:107-113.
31. Jobe B.A., Grasley A., Deveney K.E., Deveney C.W., Sheppard B.C. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg 1995, 169:480-483.
32. Rubin M.S., Bodenstein L.E., Kent K.C. Severe Clostridium difficile colitis. Dis Colon Rectum 1995, 38:350-354.
33. Eriksson S., Aronsson B. Medical implications of nosocomial infection with Clostridium difficile. Scand J Infect Dis 1989, 21:733-734.